In GBM tumors, higher expressions of production enzymes and levels of PGE2 (COX-2, mPGES-1) and PGF2α (COX-2, AKR1B1) are responsible for worse prognoses [9,121]. The gene discussed is PTGES; the disease is glioblastoma.